|
Volumn 68, Issue 2, 2001, Pages 106-108
|
TNFα inhibition in psoriatic arthritis: Cause for hope
a
CHU PURPAN
(France)
|
Author keywords
Advances in psoriatic arthritis; Etanercept; Infliximab; TNF
|
Indexed keywords
ETANERCEPT;
GLUCOCORTICOID;
INFLIXIMAB;
METHOTREXATE;
TUMOR NECROSIS FACTOR ALPHA;
ANTIRHEUMATIC AGENT;
IMMUNOGLOBULIN G;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
ANKYLOSING SPONDYLITIS;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG RESPONSE;
EDITORIAL;
ENTHESITIS;
HUMAN;
PSORIATIC ARTHRITIS;
REMISSION;
SIDE EFFECT;
DRUG ANTAGONISM;
IMMUNOLOGY;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, PSORIATIC;
HUMANS;
IMMUNOGLOBULIN G;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0034744916
PISSN: 1297319X
EISSN: None
Source Type: Journal
DOI: 10.1016/S1297-319X(01)00257-3 Document Type: Editorial |
Times cited : (5)
|
References (13)
|